GENOLUTION INC. Q3 revenue KRW 2.6 billion, operating loss KRW 2.0 billion
AI summary · Not investment advice
Genolution sold KRW 2.6 billion in Q3 but lost KRW 2.0 billion from its main business; sales rose 23.3% from a year earlier and fell 17.5% from the prior quarter.
Operating profit · 3 months
KRW -2.0 billion
Key facts
- Revenue (3 months)
- KRW 2.6 billion
- Net income (3 months)
- KRW -4.8 billion
- Period
- Q3 (cumulative Jan 1, 2026 ~ Sep 30, 2026)
- Revenue (prior-year 3 months)
- KRW 2.1 billion
- Revenue (year to date)
- KRW 8.1 billion
- Operating profit (prior-year 3 months)
- KRW -2.4 billion
- Operating profit (year to date)
- KRW -4.9 billion
- Net income (prior-year 3 months)
- KRW -1.3 billion
- Net income (year to date)
- KRW -3.9 billion
Commentary
AI commentary · Not investment advice
What happened
Genolution filed its quarterly report for Q3 2026 on a consolidated basis. Sales for the 3 months were KRW 2.55 billion. That compares with KRW 2.07 billion a year earlier. Sales rose 23.3% from a year earlier and fell 17.5% from the previous quarter.
In the company's terms
Operating profit, the money earned from the core business, was a loss of KRW 1.97 billion for the 3 months. A year earlier, the loss was KRW 2.44 billion.
What changes for shareholders
Net income, the final profit after everything, was a loss of KRW 4.85 billion for the 3 months. A year earlier, the loss was KRW 1.26 billion. The company moved from a profit in the previous quarter to a loss this quarter.
For the year to date (Jan 1 to Sep 30), sales were KRW 8.13 billion. Operating profit was a loss of KRW 4.95 billion. Net income was a loss of KRW 3.90 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
G